Bottom line
THISX vs XLV: the short answer
THISX (T. Rowe Price Health Sciences Fund, Inc.) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
But THISX is far broader, holding 279 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 0.68% — a difference of $60 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +4.3% for THISX.
Updated Nov 19, 2026
THISX vs XLV side by side
| THISX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | T. Rowe Price | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.68% | 0.08% |
| Annual cost per $10k | $68 | $8 |
| 10-yr cost on $10k (prospectus) | $847 | $103 |
| Max front load | — | None |
| 12b-1 fee | — | 0.02% |
| 1-yr return | +17.9% | +14.5% |
| 5-yr return (annualized) | +4.3% | +8.1% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | +23.5% | +14.5% |
| Worst quarter | −15.8% | −12.7% |
| Net assets (fund) | $11.9B | $40.6B |
| Number of holdings | 279 | 65 |
| Portfolio turnover | 62% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of THISX's top 25 holdings also appear in XLV's top 25.
| Holding | THISX | XLV |
|---|---|---|
| Eli Lilly & Co | 14.28% | 16.51% |
| Johnson & Johnson | 6.63% | 10.64% |
| Unitedhealth Group Inc | 5.99% | 6.57% |
| Abbvie Inc | 5.10% | 7.74% |
| Merck & Co. Inc. | 4.01% | 5.52% |
| Gilead Sciences Inc | 2.82% | 2.73% |
| Thermo Fisher Scientific Inc | 2.52% | 3.24% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.19% |
| Bristol-myers Squibb Co | 2.11% | 2.05% |
| Abbott Laboratories | 1.89% | 2.75% |
| Intuitive Surgical Inc | 1.87% | 2.45% |
| Amgen Inc | 1.82% | 3.40% |
| Stryker Corp | 1.78% | 1.89% |
| Elevance Health Inc | 1.53% | 1.46% |
| Danaher Corp | 1.43% | 2.09% |
Source: SEC Form N-PORT
THISX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between THISX and XLV?
Which is cheaper, THISX or XLV?
Should I own both THISX and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.